newsfilter
← Latest News
GlobeNewswire·

Erasca Announces Proposed Public Offering of $500 Million of Common Stock

  • Erasca Inc. (NASDAQ: ERAS) intends to sell $500.0 million of its common stock in a proposed underwritten public offering.
  • The company plans to grant underwriters a 30-day option to purchase an additional $75.0 million of shares.
  • J.P. Morgan, Morgan Stanley, Jefferies, and Evercore ISI are serving as joint book-running managers.
  • Proceeds will be used to fund research and development, working capital, and general corporate purposes.
  • The offering is conducted under a Form S-3 shelf registration statement filed with the SEC on July 13, 2026.
  • Erasca is a clinical-stage precision oncology company focused on RAS/MAPK pathway-driven cancers.